BXP vs LXRX · rev $895.7M vs rev $21.8M
Boston Properties Inc (BXP) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
BXP currently screens at market cap $12.12B. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the BXP and LXRX stock pages for the full models.
Not investment advice.